Furthermore, only half of the one-month COVID-19 convalescent patients and approximately 40% of the confirmed patients were robust neutralizers (NT50 > 1:128) against the delta variant, while all one-month convalescent PBMCs responded to alpha and delta variants spike peptide pools by producing IFN-γ and IL-2. This evidence concerns the gene IFNG and COVID-19.